Noah Clauser - 08 Feb 2024 Form 4 Insider Report for Astria Therapeutics, Inc. (ATXS)

Role
Chief Financial Officer
Signature
/s/ Noah Clauser
Issuer symbol
ATXS
Transactions as of
08 Feb 2024
Net transactions value
$0
Form type
4
Filing time
12 Feb 2024, 16:05:15 UTC
Previous filing
06 Jun 2023
Next filing
25 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATXS Stock Option (Right to Buy) Award $0 +175,000 $0.000000 175,000 08 Feb 2024 Common Stock 175,000 $15.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on February 8, 2024 and is subject to vesting over a four-year period, with 25% of the 175,000 shares underlying the option upon grant vesting on the first anniversary of February 8, 2024 and the remainder vesting over the ensuing three years in equal monthly installments.